Ontario-based Juno Pharmaceuticals says that it has created “one of the largest specialty generic injectable businesses in Canada with domestic manufacturing capabilities,” after acquiring fellow Canadian player Omega Laboratories for an undisclosed sum.
Juno described the combination as coming “at a critical time as Canada’s vulnerability to the global market continues to have...